Cannatrek deal driven by ‘critical’ need to maintain margins, says LGP boss

Scale and operational efficiency are critical in delivering viable margins in the medicinal cannabis industry, the managing director of Little Green Pharma has said, as he spoke of the rationale behind the firm’s proposed merger with Cannatrek.

Following news of the sector’s largest deal to date – confirmed by LGP after months of speculation – Paul Long said the transaction made sense for both firms in an environment where falling prices were squeezing margins.